Ishare Nq Biotch ETF (IBB) 281.44 $IBB Biotech ETF

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ishare Nq Biotch ETF (IBB) 281.44 $IBB

Biotech ETF Industry Outlook
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 2:39PM CDT
It has been a challenging environment for the biotech industry so far; how are these ETFs expected to perform for the rest of 2016.
PBE: 40.33 (+0.17), FBT: 96.15 (+0.33), XBI: 60.34 (+0.25), BBH: 113.79 (+0.10), IBB: 281.44 (+0.55)

After Yesterday's Decline of 1.12%, iShares Nasdaq Biotechnology Index Offers Investors Better Value
Comtex SmarTrend(R) - Wed Aug 31, 12:59PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $279.70 to a high of $283.41. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $282.06 on volume of 373,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 281.44 (+0.55)

Watch for iShares Nasdaq Biotechnology Index to Potentially Rebound After Falling 1.12% Yesterday
Comtex SmarTrend(R) - Wed Aug 31, 12:57PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $279.70 to a high of $283.41. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $282.06 on volume of 373,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 281.44 (+0.55)

Healthcare ETFs Need Some Rest
editor@etftrends.com (ETF Trends) - ETF Trends - Wed Aug 31, 9:48AM CDT
It has not been a typical year for healthcare exchange traded funds such as the Vanguard Health Care ETF (NYSEArca: VHT) and the Health Care Select Sector SPDR (NYSEArca: XLV). Political posturing has been weighing on the S&P 500’s...
XBI: 60.34 (+0.25), IBB: 281.44 (+0.55), VHT: 132.97 (-0.21), XLV: 72.57 (-0.19)

10 Most Read ETF Articles of the Week (August 22-26)
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Aug 26, 5:42PM CDT
Each day, ETFtrends.com publishes news, strategy and commentary on ETFs in the realms of Commodities, Currency, Equities and Smart-Beta to name a few. Here’s a look at the 10 most read articles of the week on ETF Trends, Aug. 22-26, 2016. Click the...
HYG: 86.50 (-0.20), USO: 10.06 (-0.30), GDXS: 16.70 (-1.38), GDJS: 1.90 (-0.10), XBI: 60.34 (+0.25), BNO: 13.43 (-0.36), IBB: 281.44 (+0.55), ZBIO: 23.72 (-0.11), XLV: 72.57 (-0.19), JNK: 36.44 (-0.10), BIS: 33.83 (-0.10), DUST: 37.44 (-4.77), XLF: 24.46 (-0.10), GDX: 26.42 (+0.93), LABD: 24.11 (-0.31), VHT: 132.97 (-0.21), JDST: 29.92 (-4.86)

Biotech ETFs in Focus After Mylan's EpiPen Controversy
Sanghamitra Saha - Zacks Investment Research - Fri Aug 26, 9:27AM CDT
Mylan offers discounts to the purchase of EpiPen to cool down criticism over its steep price. How will biotech ETFs take this move?
GNRX: 24.40 (-0.14), XBI: 60.34 (+0.25), MYL: 41.92 (-0.44), IBB: 281.44 (+0.55)

Did Crooked Hillary Just Take a Bite Out of Biotech Stocks?
Greg Guenthner - Daily Reckoning - Thu Aug 25, 10:19AM CDT
This post Did Crooked Hillary Just Take a Bite Out of Biotech Stocks? appeared first on Daily Reckoning . It’s no secret that the government loves to meddle in our lives. But this time they’ve gone too far—they’ve screwed with one of our trades....
IBB: 281.44 (+0.55), MYL: 41.92 (-0.44)

Did Hillary Clinton's Tweet Cause the Sell-Off in Mylan (MYL) Stock?
Ryan McQueeney - Zacks Investment Research - Wed Aug 24, 4:29PM CDT
Shares of pharmaceutical giant Mylan Inc. (MYL) fell over 5.5% in afternoon trading Wednesday after Hillary Clinton tweeted about its price hikes of the EpiPen medication.
FBT: 96.15 (+0.33), MYL: 41.92 (-0.44), IBB: 281.44 (+0.55)

iShares Nasdaq Biotechnology Index Set to Possibly Pullback After Yesterday's Rally of 1.83%
Comtex SmarTrend(R) - Mon Aug 22, 12:10PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $291.84 to a high of $296.67. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $292.88 on volume of 729,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 281.44 (+0.55)

iShares Nasdaq Biotechnology Index Rises 1.83% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Aug 22, 12:09PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $291.84 to a high of $296.67. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $292.88 on volume of 729,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 281.44 (+0.55)

Another Endorsement for Biotech ETFs
editor@etftrends.com (ETF Trends) - ETF Trends - Tue Aug 16, 10:30AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), which tracks the Nasdaq Biotechnology Index, and rival biotechnology exchange traded funds, seem to have put the woes experienced earlier this year behind them and recently have been in rally...
FBT: 96.15 (+0.33), XBI: 60.34 (+0.25), IBB: 281.44 (+0.55)

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 1.12% Rise
Comtex SmarTrend(R) - Mon Aug 15, 1:08PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $292.63 to a high of $295.91. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $294.41 on volume of 506,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 281.44 (+0.55)

15 Most Read ETF Articles of the Week (August 8-12)
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Aug 12, 5:16PM CDT
Each day, ETFtrends.com publishes news, strategy and commentary on ETFs in the realms of Commodities, Currency, Equities and Smart-Beta to name a few. Here’s a look at the Top 15 Most Viewed Articles of the Week on ETF Trends, Aug. 8-12, 2016. Click...
VTI: 111.71 (+0.06), VNM: 14.91 (-0.27), SGOL: 127.80 (+0.43), EEM: 36.81 (+0.28), GLD: 125.29 (+0.51), SIVR: 18.49 (+0.22), IBB: 281.44 (+0.55), VWO: 37.53 (+0.20), IAU: 12.65 (+0.05), PEY: 15.71 (-0.04)

Calls For Biotech ETF Rally Gain Steam
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Aug 12, 9:49AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), which tracks the Nasdaq Biotechnology Index, is higher by 9% over the past month and that is just one sign that the once downtrodden biotechnology group is rebounding. As IBB and rival biotech...
IBB: 281.44 (+0.55)

Mexico ETF: Another Central Bank Play
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Aug 12, 9:45AM CDT
Scores of single-country exchange traded funds are being affected by central bank policies this year. Count the iShares MSCI Mexico Capped ETF (NYSEArca: EWW), the largest ETF tracking stocks in Latin America’s second-largest economy, among...
IBB: 281.44 (+0.55)

The 3-letter Time Bomb in Your Portfolio
David Stockman - Daily Reckoning - Thu Aug 11, 3:21PM CDT
This post The 3-letter Time Bomb in Your Portfolio appeared first on Daily Reckoning . David Stockman explains that there will be no mighty central bank “put” to stop the sell-off or to brake the doomsday loop of an ETF sector that is nearly...
GDP: 0.16 (-0.04), IBB: 281.44 (+0.55)

SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 1.65% Loss
Comtex SmarTrend(R) - Wed Aug 10, 12:25PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $288.28 to a high of $294.41. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $293.14 on volume of 632,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 281.44 (+0.55)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Inovonics Duress Card Enhances Safety for K-12 and Beyond

Updated Category News Views 5

A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...

Continue Reading
FC2 Condom Educates NYC on Health and Wellness

Updated Category News Views 8

Union Square Becomes a Hub of Interactivity The heart of NYC pulsed with purpose as FC2 Female Condom set up shop in Union Square, using the iconic location as a stage for a different kind of celebration. Clear Future, the manufacturer behind FC2, marked Global Female Condom Day with an event unlike any other. It wasn't just about the product—it was a call to educate...

Continue Reading
MSP360 Unveils Free Proxmox Backup: A Game Changer?

Updated Category News Views 7

Backing Up: New Paths for Proxmox Users Ever get that feeling of uncovering something truly worth its weight in gold? That's what MSP360 just dropped on us, with their new backup solution for Proxmox that won’t cost you a dime upfront. They're calling it the Community Edition, and it’s not only free, but it comes with all the bells and whistles for protecting those...

Continue Reading
Postal Connections Expands with New Hillsboro Opening

Updated Category News Views 4

Expanding Horizons in Hillsboro In the world of postal and office services, Annex Brands, Inc. is making headlines by launching yet another Postal Connections spot, this time planting its flag in the tech-centric town of Hillsboro, Oregon. Spearheaded by Jason Rautenkranz, this expansion is more than just another dot on a map—it's a strategic push into one of the...

Continue Reading
G-STAR & Wu-Tang Clan Unleash Denim Fusion

Updated Category News Views 4

Denim and Old-School Beats: A Fresh Partnership Just when you think fashion collaborations have run their course, along comes something worth the buzz. This fall, G-STAR, the edgy Dutch denim frontrunner, and the legendary hip-hop collective of Wu-Tang Clan are shaking up the apparel scene, blending raw denim with raw rap. It's a multi-year collaboration that doesn't slap...

Continue Reading
Lumicell Expands LumiSystem in Breast Cancer Surgery

Updated Category News Views 6

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

Continue Reading
Mutare Sharpens Security for Webex Calls with Precision

Updated Category News Views 4

Control Dialed In: Tailored Call Screening Kicking things up a notch, Mutare is redefining call security by fine-tuning their Voice Security for Webex Calling. Imagine this—custom rules now let organizations shape a security policy down to the very last detail, ensuring unwanted calls don’t slip through the cracks. Wave goodbye to the broad-strokes approach. Precision...

Continue Reading
Cabot Wilds: Nova Scotia's Next Luxury Golf Haven

Updated Category News Views 6

Breaking New Ground in Golf and Luxury Cabot and the Bragg family are cooking up something extraordinary in Cumberland County, Nova Scotia. The new luxury lifestyle and golf destination, Cabot Wilds, promises to be more than just a retreat—it's a bold statement on how to marry nature, luxury, and community. Set to open in late 2027, this expansive 2,500-acre resort will...

Continue Reading
MasterBrand's 2027 Kitchen Trends: Embrace Warmth

Updated Category News Views 4

Wood Finishes and the Warm Embrace Alright folks, let's cut through the fluff and get to the heart of the matter: wood finishes are making a roaring comeback in 2027 kitchens. And it's not just some passing phase, we're talking a comprehensive shift toward warmer and more natural kitchen designs. MasterBrand, Inc. isn't just throwing darts at a board here. They surveyed a...

Continue Reading
Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 7

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading

Top 5 Most Recently Viewed Articles

Barley Farmers Face Challenges Amid Declining Beer Demand

Updated Category News Views 129

Barley Farmers Confront New Challenges Amidst Declining Beer Consumption The beverage landscape is evolving quickly, presenting barley farmers across the United States with significant hurdles. One farmer, Don Nygaard, who has traditionally grown malt barley for various breweries, finds himself without contracts this year. As a result, he's pivoting to cultivate...

Continue Reading
Grand Opening of New Diamond Approach Facility in Boulder

Updated Category News Views 77

So, here we go. The Colorado Diamond Approach Center just kicked off its new digs—a big deal for folks looking to dive into their spiritual side. Rebirth After the Flames: A Community's Resilience This place is more than bricks and mortar; it’s a beacon for self-discovery. You remember when that original center went up in smoke thanks to the Marshall Fire? Yeah, that...

Continue Reading
Teva Pharmaceutical's Upcoming Presentations for Investors

Updated Category News Views 134

Teva Pharmaceutical Industries Ltd. to Present at Investor Conferences Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has exciting news for investors. Richard Francis, the President and CEO of Teva, is set to present at two significant investor conferences this November. These events aim to highlight the company's ongoing commitment to innovation in...

Continue Reading
Understanding the Class Action Against Symbotic Inc. (SYM)

Updated Category News Views 58

Overview of the Class Action for Symbotic Inc. Shareholders The legal environment is evolving, and shareholders of Symbotic Inc. (NASDAQ: SYM) should stay informed. A class action lawsuit has recently been filed, providing an opportunity for those impacted to seek justice and potential compensation. This development follows important announcements from the company...

Continue Reading
Alisher Usmanov Successfully Challenges Sanction Allegations in Court

Updated Category News Views 485

Alisher Usmanov Wins Legal Battle Against False Allegations The Hamburg Regional Court recently ruled in favor of Alisher Usmanov in a groundbreaking case against unfounded claims that he used his sister to hide assets, boosting hope for his family's reputation. The allegations, which mentioned illicit asset concealment in Swiss bank accounts, were instrumental in...

Continue Reading